Walk into any Indian pharmacy and you will find an entire aisle of multivitamins, protein powders, omega-3 capsules, and “immunity boosters.” Patients ask about them constantly — not “should I take a supplement,” but “which one.” As doctors, our job isn’t to dismiss the question or endorse a brand. It’s to give an answer grounded in evidence, not marketing.
I’ve written before about what the NMC guidelines actually say about doctors selling supplements — the ethics of commercial interest. This post is the clinical companion to that: how to evaluate whether a supplement is actually worth recommending, and how to do it without compromising the doctor-patient relationship.
Start From Deficiency, Not Demand
The single biggest mistake in supplement recommendations — by doctors and patients alike — is treating supplementation as a default rather than a correction. A supplement corrects a documented or highly probable deficiency. It is not a general-purpose insurance policy against poor diet.
The NIH Office of Dietary Supplements maintains fact sheets reviewed by nutrition scientists for nearly every common supplement — vitamin D, B12, iron, omega-3s, probiotics — covering what the evidence actually supports, typical dosing, and who is genuinely at risk of deficiency. It’s one of the few sources I trust enough to link patients to directly, because it doesn’t sell anything.
Before recommending any supplement, I ask three questions:
- Is there a documented deficiency? Ideally via a blood test — vitamin D, B12, ferritin, and HbA1c-adjacent markers are cheap and widely available in India now.
- Is the deficiency common in this population? Vitamin D deficiency is extremely common in urban India despite abundant sunlight, largely due to indoor lifestyles and pollution-linked reduced UV exposure. B12 deficiency is common in vegetarian and vegan patients. These are legitimate, evidence-backed reasons to supplement.
- Does the evidence support supplementation over dietary correction? For iron and B12, yes, often. For antioxidant “immunity” blends, rarely — the evidence is thin, and food sources are just as effective in the absence of true deficiency.
The India-Specific Problem: An Unregulated Middle Ground
Most supplements sold in India are classified as nutraceuticals under FSSAI, not as drugs under CDSCO. That distinction matters clinically: nutraceuticals face far lighter efficacy and manufacturing scrutiny than pharmaceuticals. A product can be legally sold with a label claim that has never been tested in a clinical trial.
This is exactly the gap Dofody was built to close. In “Behind the Label: How Dofody is Cleaning Up India’s Broken Supplement Market”, we go into why label transparency — actual tested dosages, sourcing, and third-party verification — is the exception rather than the rule in this market, and what it takes to fix that.
As a prescribing physician, this is the layer most doctors never see: by the time a patient asks “is this brand good,” they’ve usually already bought it. The more useful intervention is teaching patients what to check before they buy — and that’s a conversation worth having in every consultation where diet or fatigue comes up.
What to Actually Tell Patients
1. A blood test beats a guess
If a patient asks about vitamin D, B12, or iron supplementation, the right first step is testing, not prescribing blind. It’s inexpensive, avoids unnecessary supplementation (excess fat-soluble vitamins like A and D can accumulate to toxic levels), and gives you a baseline to reassess in 3 months.
2. Check the label like you’d check a prescription
Elemental dose, not just compound weight. FSSAI license number. Manufacturing and expiry dates. Third-party testing certification where available. Most patients have never been taught to read a supplement label critically — a two-minute explanation during a consult goes a long way.
3. Food first, supplement second
For the majority of nutrients, dietary correction is as effective as supplementation and comes with none of the risk of excess. Supplementation is the right call when diet alone can’t close the gap fast enough, or when absorption is impaired (e.g., B12 in patients on long-term metformin, or post-bariatric surgery patients).
4. Disclose your own interest, always
If you stock or recommend a specific brand you have any financial relationship with, say so — plainly, at the time of the recommendation. This isn’t just an NMC compliance point; it’s what keeps the recommendation credible in the patient’s eyes.
Where This Leaves Home Practice and Telemedicine
For doctors running telemedicine consultations, supplement questions come up constantly precisely because patients can’t casually swing by a pharmacy counter and ask. That makes the doctor’s answer carry more weight, not less. A five-minute explanation of “here’s why I’m recommending this, here’s the evidence, here’s what to check on the label” is a better use of a consultation than a brand name typed into a chat window.
If you’re building a supplement recommendation into your own practice, our shop page is a working example of what transparent, doctor-reviewed sourcing looks like at scale — every product entry includes the clinical rationale, not just a marketing description.
The Bottom Line
Supplementation done well is evidence-driven, deficiency-corrected, and transparently disclosed. Supplementation done poorly is demand-driven, unverified, and quietly profitable for whoever’s selling it. The difference isn’t the product — it’s the process a doctor uses to get there. Bring that same rigor to a five-minute OPD conversation about vitamin D as you would to any other clinical decision, and the label reading takes care of itself.
Have a supplement question worth a full clinical breakdown — creatine, protein powders, ashwagandha? Let us know in the comments and we’ll cover it in a future post.
